Definiens’ technology is used in the development of clinical diagnostics in predictive and prognostic settings. This typically involves the correlation of multi-dimensional quantitative readouts describing morphological aspects and/or biomarker expression against patient outcome data. The technology can also identify subsets of descriptors that together have a better predictive or prognostic impact. The greater refinement of continuous scale quantification leads to powerful diagnostics and better treatment decisions.